FDA green lights early access to pancreatic cancer drug, daraxonrasib
- Posted on May 1, 2026
- By Usa Today
- 0 Views
- 1 min read
FDA green lights early access to pancreatic cancer drug, daraxonrasib
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug daraxonrasib.
